Trials / Unknown
UnknownNCT02578303
Association Between Cerebral Arterial Vascular Flow and Sleep Apnea in Neurodegenerative Alterations
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 139 (estimated)
- Sponsor
- Central Hospital Saint Quentin · Other Government
- Sex
- All
- Age
- 75 Years – 120 Years
- Healthy volunteers
- Accepted
Summary
Obstructive sleep apnea syndrome (OSAS) is a sleep-disordered breathing characterized by the occurrence of repeated upper airway obstructions leading to airflow reduction (hypopnea) or cessation (apnea). The apnea-hypopnea index (AHI) is the number of apneas and hypopneas per hour of sleep. OSA patients often report cognitive complaints. About 25% of the elderly population is affected by this syndrome with a drastic increase of this rate among dementia patients. OSAS is considered to be an important risk factor for the development of hypertension, heart disease and stroke.
Detailed description
Numerous studies pointed out the close relationship between sleep apnea and cognitive impairment. To the investigators' knowledge, no trials have assessed the existence of a relationship between the IAH index and the cerebral arterial blood flow rate (macrocirculation). Developments in magnetic resonance imaging (MRI) provide new insights into the quantitative study of blood flow through phase contrast MRI also called "flow MRI". The main hypothesis tested in this study is the existence of a relationship between OSAS and total cerebral arterial vascular inflow measured by PC-MRI (in mL/min) in the elderly population. * Primary outcome: The apnea/hypopnea index (measured by nocturnal respiratory polygraphy) and total arterial flow rate (measured by PC-MRI) * Secondary outcomes: 1. Measurement of arrhythmia 2. Measurement of arterial blood pressure
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Vascular flow measurement by PC-MRI | participants will undergo vascular flow measurement by PC-MRI at intra and extracranial levels |
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2022-01-01
- Completion
- 2022-01-01
- First posted
- 2015-10-16
- Last updated
- 2020-07-14
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02578303. Inclusion in this directory is not an endorsement.